Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S ribosomal subunit 16S rRNA decoding site, often referred to as the A-site, is a critical functional region of the ribosome responsible for ensuring the fidelity of genetic code translation. It specifically monitors the base-pairing between the mRNA codon and the tRNA anticodon, facilitating the selection of the correct aminoacyl-tRNA during protein synthesis (PubMed: 10591207). This site is the primary pharmacological target for aminoglycoside antibiotics, which bind to the highly conserved 16S rRNA sequences to disrupt bacterial translation. By inducing conformational changes that stabilize non-cognate tRNA binding, these drugs cause extensive mistranslation and eventual bacterial cell death (PubMed: 11054811). While highly effective against a broad spectrum of Gram-negative and some Gram-positive bacteria, the structural similarity between the bacterial decoding site and the human mitochondrial 12S rRNA decoding site can lead to significant clinical toxicities, such as permanent hearing loss and renal impairment (PubMed: 12551903). Understanding the molecular architecture of this site is essential for the development of next-generation antibiotics designed to overcome prevalent resistance mechanisms like rRNA methylation.
Drugs targeting this site typically bind to the internal loop of the 16S rRNA helix 44, inducing a conformational change in highly conserved adenine residues (A1492 and A1493). This stabilization of the 'flipped-out' state mimics the cognate tRNA-mRNA interaction, leading to the incorporation of incorrect amino acids (mistranslation) or the complete inhibition of translocation and protein synthesis (PubMed: 11054811, PubMed: 11557166).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S ribosomal subunit 16S rRNA decoding site (16S rRNA A-site).